Acurian and Synexus have launched SynexusPlus, an integrated site solution for enrolling patients in clinical studies.
SynexusPlus combines the global site network of Synexus with Acurian’s patient enrollment engine to create a closed-loop process that can be tailored to the specific requirements of any study, such as the need for more patients, faster startup, site footprint reduction, front-loaded enrollment or enrollment completion within a specific timeframe.
Acurian and Synexus are offering SynexusPlus to trial sponsors and CROs as a new clinical development paradigm of enrollment and budget certainty.
Synexus and Acurian are part of Accelerated Enrollment Solutions (AES), a business unit of PPD, the global contract research organization (CRO).
“With SynexusPlus, customers benefit from one solution with two world-class proficiencies,” said Roger Smith, senior vice president and general manager of AES. “Through this collaborative effort between these leaders in their respective fields, we can package and prioritize all of the components of site and enrollment conduct, and more precisely control the enrollment of study participants for a new standard in clinical trial productivity.”
Under the results-based construct of SynexusPlus, the trial delivery budget incorporates all recruitment, site, investigator grant and other fees from Synexus and Acurian into a single price per patient.